Regulatory authorities in Japan have approved Sanofi’s oral therapy Wayrilz (rilzabrutinib) for treating people with immune thrombocytopenia (ITP) who haven’t responded to,…
News
Dangerous blood clots that block blood flow are rare in people with von Willebrand disease (VWD), but their risk increases with age and the…
Four weekly injections of the antibody therapy daratumumab restored a key enzyme’s activity and triggered a two-year recovery for a woman with hard-to-treat immune-mediated…
A donor stem cell transplant and follow-up treatments helped a teenage girl achieve long-term remission from refractory immune thrombocytopenia (ITP), according to a case…
Neutrophil extracellular traps — web-like structures released by immune cells that can promote clotting — are increased during acute episodes and clinical relapses of immune-mediated…
A mutation in the gene ELF4 likely set the stage for a teenage boy to develop immune thrombocytopenia (ITP), according to a new report. The…
People with von Willebrand disease (VWD) had lower bone mineral density than healthy individuals in a small, single-center study, highlighting the need to consider…
Two teenage brothers in Egypt have been diagnosed with an extremely rare combination of two distinct genetic blood-clotting disorders. The boys carry the genetic mutations…
A 96-year-old woman with inherited type 2A von Willebrand disease and previously mild symptoms experienced a sudden worsening of bleeding after developing acquired von…
Adding Cablivi (caplacizumab-yhdp) to standard treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) may help protect the brain by repairing damage to the blood-brain barrier,…
